BHF Stock Analysis: Buy, Sell, or Hold?
BHF - Brighthouse Financial, Inc.
$52.27
-0.95 (-1.79%)
▼
5d:
-10.92%
30d:
-16.66%
90d:
-16.65%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When BHF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BHF is down 10.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BHF is down 10.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$86.28
Based on 6.7% avg growth
INTRINSIC VALUE TODAY
$53.57
2.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BHF is currently trading at $52.27, which is considered oversold relative to its 30-day fair value range of $58.45 to $65.15. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.6) compared to its historical average (3.1). Remarkably, the market is currently pricing in an annual earnings decline of 5.8% over the next few years. This pessimistic expectation contrasts with the company's recent 1520.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BHF is showing sideways momentum. The price is currently testing key support at $52.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BHF scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $65.00 (+24.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BHF is showing sideways momentum. The price is currently testing key support at $52.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BHF scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $65.00 (+24.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$58.45 -
$65.15
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.4% below Wall St target ($65.00)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$58.45 -
$65.15
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$52.04
Resistance Level
$60.90
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.60
Wall Street Target
$65.00
(+24.4%)
Revenue Growth (YoY)
86.7%
Earnings Growth (YoY)
1520.6%
Profit Margin
12.2%
Valuation Discount vs History
-5.8% cheaper
PE vs Historical
2.6 vs 3.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.8%
(market-implied from PE analysis)
1-Year Target
$49.24
(-6%)
2-Year Target
$46.38
(-11%)
3-Year Target
$43.69
(-16%)
3-Yr Target (if PE normalizes)
(PE: 3→3)
$52.19
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 9.4%)
$529.42
(+913%)
Base:
(SPY PE: 2.6, Growth: 9.4%)
$68.46
(+31%)
Bear:
(PE: 2.2, Growth: 9.4%)
$58.19
(+11%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (4x PE), but valuation improves significantly next year (3x PE) as earnings recover.
Trailing PE: 4.21 | Current EPS (TTM): $12.61
Bull Case
$93.29
(+79%)
Analyst growth 59.7%, PE expands to 4.6
Base Case
$84.81
(+62%)
Market implied 59.7%, PE stable at 4.2
Bear Case
$36.11
(-31%)
Severe decline -20.0%, PE contracts to 3.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.6 to 3.1
Stabilization Target:
$62.43
(+19.4%)
PE Expansion Potential:
+19.4%
Share & Embed Analysis
Last updated: August 23, 2026 6:26 AM ET
Data refreshes hourly during market hours. Next update: 7:26 AM
Data refreshes hourly during market hours. Next update: 7:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BHF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MET
MetLife Inc |
STRONG BUY
16 analysts |
$104 | 36 SELL |
|
UNM
Unum Group |
BUY
13 analysts |
$101 | 53 HOLD |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 42 HOLD |
|
MFC
Manulife Financial Corp |
BUY
13 analysts |
$34 | 33 SELL |
|
GL
Globe Life Inc |
BUY
10 analysts |
$194 | 33 SELL |
